TSCAN THERAPEUTICS, INC. (TCRX) ROI
- 2026-06-30: ROI -115.63%.
- 2024-06-30: ROI -36.55%.
- 2024-03-31: ROI -63.18%.
- 2023-12-31: ROI -49.32%.
Complete source-backed roi history.
- Available history
- 2023-09-30 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | -115.63% |
| 2024-06-30 | -36.55% |
| 2024-03-31 | -63.18% |
| 2023-12-31 | -49.32% |
| 2023-09-30 | -44.41% |
Annual ROI
| Date | ROI |
|---|---|
| 2023-12-31 | -49.32% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |